Managing Anxiety in Pediatric Primary Care (MAPP) Study
This study, called MAPP, is looking at a behavioral intervention (a type of therapy) to help children and teenagers with anxiety. The intervention, named MAPP, is based on exposure therapy strategies, which help people gradually face their fears. The goal is to see if primary care providers (like pediatricians or nurse practitioners) can effectively deliver this brief intervention, called the Anxiety Action Plan (AxAP), to reduce anxiety in young people. This could make it easier for more kids to get help for anxiety, especially where there aren't many mental health specialists. The study plans to enroll 60 participants aged 6 to 17 years old who have elevated anxiety symptoms. Researchers will measure how much anxiety symptoms improve at 2 months and 6 months after the intervention starts. The study's current status is unclear.
- Study design
- This is an interventional study planning to enroll 60 participants. It is a randomized controlled trial designed to test the feasibility of a behavioral intervention.
- What's involved
- Youth will be assessed at 2 months (post intervention) and 6 months after they are eligible for the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after eligibility is established.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Managing Anxiety in Pediatric Primary Care (MAPP)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Golda S Ginsburg, PhD · PRINCIPAL_INVESTIGATOR · UConn Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinical Global Impression Improvement scaleYouth will be assessed at 2 months (post intervention) and 6 months after eligibility is established.
Improvement in anxiety symptoms and related functioning since baseline (a score of 1 or 2 is defined as a responder; scores of 3-7 are defined as non-responders).
- Primary Care Provider Primary outcomePost intervention (i.e., 2 months after first family enrolled)
Satisfaction with MAPP: 70% of PCPs endorsing a score of 3 (somewhat helpful) or higher on a question asking "how helpful they perceived the program to be"; scores range from 0 (not at all helpful) to 4 very helpful.